메뉴 건너뛰기




Volumn 40, Issue 9, 2012, Pages 2737-2738

Antifungal therapy in the critically ill: In medio stat virtus: Is a preemptive approach correct?

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

EID: 84865515239     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318258ebb2     Document Type: Letter
Times cited : (2)

References (8)
  • 1
    • 84857648821 scopus 로고    scopus 로고
    • Systemic antifungal therapy in critically ill patients without invasive fungal infection
    • Azoulay E, Dupont H, Tabah A, et al: Systemic antifungal therapy in critically ill patients without invasive fungal infection. Crit Care Med 2012; 40:813-822
    • (2012) Crit Care Med , vol.40 , pp. 813-822
    • Azoulay, E.1    Dupont, H.2    Tabah, A.3
  • 2
    • 0242323689 scopus 로고    scopus 로고
    • Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
    • Eggimann P, Garbino J, Pittet D: Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3:685-702
    • (2003) Lancet Infect Dis , vol.3 , pp. 685-702
    • Eggimann, P.1    Garbino, J.2    Pittet, D.3
  • 3
    • 0037451929 scopus 로고    scopus 로고
    • The epidemiology of sepsis in the United States from 1979 through 2000
    • Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554
    • (2003) N Engl J Med , vol.348 , pp. 1546-1554
    • Martin, G.S.1    Mannino, D.M.2    Eaton, S.3
  • 4
    • 0345414664 scopus 로고    scopus 로고
    • Management of Candida species infections in critically ill patients
    • Eggimann P, Garbino J, Pittet D: Management of Candida species infections in critically ill patients. Lancet Infect Dis 2003; 3:772-785
    • (2003) Lancet Infect Dis , vol.3 , pp. 772-785
    • Eggimann, P.1    Garbino, J.2    Pittet, D.3
  • 5
    • 0037109554 scopus 로고    scopus 로고
    • Effects of nosocomial candidemia on outcomes of critically ill patients
    • Blot SI, Vandewoude KH, Hoste EA, et al: Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 2002; 113:480-485
    • (2002) Am J Med , vol.113 , pp. 480-485
    • Blot, S.I.1    Vandewoude, K.H.2    Hoste, E.A.3
  • 6
    • 0033796346 scopus 로고    scopus 로고
    • Practice guidelines for the treatment of candidiasis Infectious Diseases Society of America
    • Rex JH, Walsh TJ, Sobel JD, et al: Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 2000; 30:662-678
    • (2000) Clin Infect Dis , vol.30 , pp. 662-678
    • Rex, J.H.1    Walsh, T.J.2    Sobel, J.D.3
  • 7
    • 33845708554 scopus 로고    scopus 로고
    • Does antibiotic selection impact patient outcome?
    • Harbarth S, Nobre V, Pittet D: Does antibiotic selection impact patient outcome? Clin Infect Dis 2007; 44:87-93
    • (2007) Clin Infect Dis , vol.44 , pp. 87-93
    • Harbarth, S.1    Nobre, V.2    Pittet, D.3
  • 8
    • 0027942475 scopus 로고
    • Candida colonization and subsequent infections in critically ill surgical patients
    • Pittet D, Monod M, Suter PM, et al: Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220:751-758
    • (1994) Ann Surg , vol.220 , pp. 751-758
    • Pittet, D.1    Monod, M.2    Suter, P.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.